- Thursday
- June 30th, 2022
Researchers at Indiana University School of Medicine are learning more about how special regulatory T cells can impact the immune system's response and how those cells could be manipulated for potential treatments for food allergies and autoimmune diseases. In a...
The Universidad Carlos III de Madrid (UC3M) is conducting research that analyses antibiotic resistance patterns with the aim of finding trends that can help decide which treatment to apply to each type of patient and stop the spread of bacteria....
Carbon monoxide is best known as a potentially deadly gas. However, in small doses it also has beneficial qualities: It has been shown to reduce inflammation and can help stimulate tissue regeneration. A team of researchers led by MIT, Brigham...
A new study suggests the risk of miscarriage may increase in the summer, which researchers say could indicate a link between extreme heat and pregnancy loss. The study out of Boston University School of Public Health, published in the journal...
Researchers have gained ground in understanding unique immune cells equipped to remember the identities of malicious invaders. The researchers developed a new atlas that describes tissue-resident memory T cells in diverse tissue settings, boosting the prospects of the development of...
Myotonic dystrophy type 1 (DM1) is the most common form of muscular dystrophy, characterized by progressive muscle wasting and weakness and caused by abnormally repetitive DNA segments that are transcribed into toxic molecules of RNA. Instead of ferrying a gene's...
OTTAWA - The National Advisory Committee on Immunization is recommending booster shots this fall in advance of a possible future wave of COVID-19 in Canada. In a release Wednesday, NACI says jurisdictions should plan to offer boosters to people who...
Women who have gone through menopause may have more of a brain biomarker called white matter hyperintensities than premenopausal women or men of the same age, according to a new study published in the June 29, 2022, online issue of...
Histone deacetylase (HDAC) inhibitors are a class of drugs used in oncology. An international research team involving scientists at the Technical University of Munich (TUM), Cornell University in Ithaca (USA), the German Cancer Research Center (DKFZ) in Heidelberg and Martin...

All posts loaded
No more posts